CCCharity

Posts

Showing posts from July, 2018

Educating Patients about Genetic Test Results: An Interview with Carol Weil about the COMET Study

Developing Biomarkers for Immunotherapy: A Conversation with Drs. Magdalena Thurin and Helen Chen

Engaging the public about the promise of cancer immunotherapy at Science Museum Lates

First ever Teaching Week to promote the ICR’s academic excellence

FDA Alters Approved Use of Two Checkpoint Inhibitors for Bladder Cancer

More than your average spreadsheet - one PhD student's quest to understand cancer genetics

Faces of Blue: Michael Alexander Robinson

Study Confirms Benefits of Early Palliative Care for Advanced Cancer

PhD students reflect on life at the ICR

Why them and not me?

Avelumab Induces Sustained Tumor Responses in Some Patients with Rare Skin Cancer

ICR top in UK for commercial earnings for the second year running

New on NCI Websites for October 2016

Metabolomics Study Reveals another Energy Source for Cancer Cells

Modified Immunotherapy Approach Shows Promise for Leukemia

DINO RNA Molecule Triggers Anticancer Response in Damaged Cells

ICR Awards Ceremony celebrates graduating students and pioneering researchers

Research News: FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) combination for MSI-H/dMMR Metastatic Colorectal Cancer Patients

Our teaching excellence – and why we don't feature in the Teaching Excellence Framework results

Big Bird, Galápagos and Cancer – How studying nature helps us understand evolution in cancer

‘Unexpected’ Vulnerability Creates Treatment Opportunity in Aggressive Type of Lung Cancer

‘Expanding my knowledge’ – a Q&A with one of our MSc in Oncology students

Scientists Identify Potential Marker of Resistance to PARP Inhibitors

Olaratumab Approved to Treat Advanced Soft Tissue Sarcoma

ICR awarded £30 million towards new Centre for Cancer Drug Discovery

Mouse Study Links Immune Cells to Diarrhea Caused by Chemotherapy

Scientists call for better use of chemical tools to improve cancer drug discovery

Call to bioscientists: choose and use your chemicaI probes very carefully

How we’re making radiotherapy a smarter, kinder treatment for cancer

New: Gather Voices App for August Recess Challenge

World-leading cancer researchers first in UK to receive NovaSeq - the latest genome sequencing technology

International Medical Graduates Work on Screening in Immigrant Communities

A Very Special Centenary Skydive

Boys one step closer to receiving cancer-protecting HPV vaccine after committee approval

ICR commended for plans to work with commercial partners

Scientists uncover DNA ‘shield’ with crucial roles in normal cell division, the immune system and cancer

Symposium Brings Rising Global Cancer Burden into Focus

rss

Pioneering leukaemia and evolution researcher – Professor Mel Greaves – wins prestigious Royal Society award

CDC Updates Recommendations on HPV Vaccine

A Walk Across America- From An Insider

Scientists discover new line of attack against cancer

ICR part of major MedTech commercialisation programme

More Immunotherapy Options Approved for Lung Cancer

The Opioid Epidemic and Cancer Pain Management: A Conversation with Dr. Judith Paice

Tiny changes in prostate cancer blood test could spot early warning signs of treatment not working

Connected Health: An Important Tool for Making Progress against Cancer

New computer program makes it easier to track living cells

NCI’s Office of Cancer Survivorship: Celebrating 20 Years, Planning for Continued Progress

Device Uses Cancer Cells' Mass to Predict Response to Treatment

Prescription Subsidies Reduce Breast Cancer Treatment Disparities

FDA Approves Nivolumab for Head and Neck Cancer

Sodium Thiosulfate Prevents Cisplatin-Induced Hearing Loss in Some Children

Training as an oncologist in a top-quality research environment: an ICR clinical student shares their experiences

Immune-Cell Traps May Aid Cancer Metastasis

ICR holds first networking event for scientists and commercial partners

FDA Approves New Use for Daratumumab in Multiple Myeloma

Single Tumor Cells Reveal Clues to Biology of Multiple Myeloma

Faces of Blue: Rosetta VanPelt

Brain Cancer’s Cholesterol Addiction May Offer New Treatment Strategy

New Mouse Model Closely Mimics Most Common Leukemia in Infants

Keeping it Real: Appropriations 101

New Targeted Therapies Show Promise for Treating Advanced GIST

Broadcaster Victoria Derbyshire and former Cancer Research UK CEO Sir Harpal Kumar awarded honorary doctorates

Over Eighty Colorectal Cancer Advocates to Summit Quandary Peak